The conflicting safety signal One real-world evidence study found that patients receiving GLP-1 receptor agonists had higher risks of certain autoimmune conditions, including ulcerative colitis, rheumatoid arthritis, autoimmune thyroiditis, ankylosing spondylitis, and psoriasis, compared to those on DPP-4 inhibitors
[1] For more persistent symptoms, your GP may recommend: H2-receptor antagonists (such as famotidine) Proton pump inhibitors (PPIs) like omeprazole or lansoprazole for more severe or chronic symptoms Patients should consult their GP or diabetes specialist nurse before starting any new medications, as some treatments may interact with Rybelsus or affect diabetes management
Medicare, through Part D, currently covers the medications only for patients with type 2 diabetes, obstructive sleep apnea, or noncirrhotic metabolic dysfunction-associated steatohepatitis
When the stomach empties slower than usual, it can lead to an uncomfortable gas buildup